Martin McMahon - Publications

Biochemistry and Molecular Biology University of California, San Francisco, San Francisco, CA 
Molecular Biology, Cell Biology, Biochemistry, Oncology

15 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2019 van Veen JE, Scherzer M, Boshuizen J, Chu M, Liu A, Landman A, Green S, Trejo C, McMahon M. Mutationally-activated PI3'-kinase-α promotes de-differentiation of lung tumors initiated by the BRAF oncoprotein kinase. Elife. 8. PMID 31452510 DOI: 10.7554/Elife.43668  0.44
2019 Veen JEv, Scherzer M, Boshuizen J, Chu M, Liu A, Landman A, Green S, Trejo C, McMahon M. Author response: Mutationally-activated PI3’-kinase-α promotes de-differentiation of lung tumors initiated by the BRAFV600E oncoprotein kinase Elife. DOI: 10.7554/Elife.43668.050  0.44
2016 Merlino G, Herlyn M, Fisher DE, Bastian BC, Flaherty KT, Davies MA, Wargo JA, Curiel-Lewandrowski C, Weber MJ, Leachman SA, Soengas MS, McMahon M, Harbour JW, Swetter SM, Aplin AE, et al. The state of melanoma: challenges and opportunities. Pigment Cell & Melanoma Research. PMID 27087480 DOI: 10.1111/Pcmr.12475  0.44
2015 Green S, Trejo CL, McMahon M. PIK3CAH1047R Accelerates and Enhances KRASG12D-Driven Lung Tumorigenesis. Cancer Research. 75: 5378-91. PMID 26567140 DOI: 10.1158/0008-5472.Can-15-1249  0.44
2015 Shai A, Dankort D, Juan J, Green S, McMahon M. TP53 Silencing Bypasses Growth Arrest of BRAFV600E-Induced Lung Tumor Cells In a Two-Switch Model of Lung Tumorigenesis. Cancer Research. PMID 26001956 DOI: 10.1158/0008-5472.Can-14-3701  0.44
2015 Lin L, Sabnis AJ, Chan E, Olivas V, Cade L, Pazarentzos E, Asthana S, Neel D, Yan JJ, Lu X, Pham L, Wang MM, Karachaliou N, Cao MG, Manzano JL, ... ... McMahon M, et al. The Hippo effector YAP promotes resistance to RAF- and MEK-targeted cancer therapies. Nature Genetics. 47: 250-6. PMID 25665005 DOI: 10.1038/Ng.3218  0.44
2015 Damsky W, Micevic G, Meeth K, Muthusamy V, Curley DP, Santhanakrishnan M, Erdelyi I, Platt JT, Huang L, Theodosakis N, Zaidi MR, Tighe S, Davies MA, Dankort D, McMahon M, et al. mTORC1 activation blocks BrafV600E-induced growth arrest but is insufficient for melanoma formation. Cancer Cell. 27: 41-56. PMID 25584893 DOI: 10.1016/J.Ccell.2014.11.014  0.44
2015 Green S, McMahon M. Abstract A37: PI3-kinase signaling is rate limiting for KRASG12D-driven lung tumorigenesis but is not required for tumor maintenance Molecular Cancer Therapeutics. 14. DOI: 10.1158/1538-8514.Pi3K14-A37  0.44
2014 Silva JM, McMahon M. The fastest Western in town: a contemporary twist on the classic Western blot analysis. Journal of Visualized Experiments : Jove. e51149. PMID 24561642 DOI: 10.3791/51149  0.44
2014 Silva JM, Bulman C, McMahon M. BRAFV600E cooperates with PI3K signaling, independent of AKT, to regulate melanoma cell proliferation. Molecular Cancer Research : McR. 12: 447-63. PMID 24425783 DOI: 10.1158/1541-7786.Mcr-13-0224-T  0.44
2013 Trejo CL, Green S, Marsh V, Collisson EA, Iezza G, Phillips WA, McMahon M. Mutationally activated PIK3CA(H1047R) cooperates with BRAF(V600E) to promote lung cancer progression. Cancer Research. 73: 6448-61. PMID 24019382 DOI: 10.1158/0008-5472.Can-13-0681  0.44
2013 Strohecker AM, Guo JY, Karsli-Uzunbas G, Price SM, Chen GJ, Mathew R, McMahon M, White E. Autophagy sustains mitochondrial glutamine metabolism and growth of BrafV600E-driven lung tumors. Cancer Discovery. 3: 1272-85. PMID 23965987 DOI: 10.1158/2159-8290.Cd-13-0397  0.44
2012 Collisson EA, Trejo CL, Silva JM, Gu S, Korkola JE, Heiser LM, Charles RP, Rabinovich BA, Hann B, Dankort D, Spellman PT, Phillips WA, Gray JW, McMahon M. A central role for RAF→MEK→ERK signaling in the genesis of pancreatic ductal adenocarcinoma. Cancer Discovery. 2: 685-93. PMID 22628411 DOI: 10.1158/2159-8290.Cd-11-0347  0.44
2012 Trejo CL, Juan J, Vicent S, Sweet-Cordero A, McMahon M. MEK1/2 inhibition elicits regression of autochthonous lung tumors induced by KRASG12D or BRAFV600E. Cancer Research. 72: 3048-59. PMID 22511580 DOI: 10.1158/0008-5472.Can-11-3649  0.44
2008 Cartlidge RA, Thomas GR, Cagnol S, Jong KA, Molton SA, Finch AJ, McMahon M. Oncogenic BRAF(V600E) inhibits BIM expression to promote melanoma cell survival. Pigment Cell & Melanoma Research. 21: 534-44. PMID 18715233 DOI: 10.1111/J.1755-148X.2008.00491.X  0.44
Show low-probability matches.